Datamonitor Healthcare provides timely, in-depth analysis of the pharmaceutical and biotechnology industries
Joined July 2012
- Tweets3.3K
- Following686
- Followers1.3K
- Likes635
Datamonitor HC, Citeline Commercial retweeted
Worldwide, #CervicalCancer remains one of the gravest threats to women's lives.
We can eliminate cervical #cancer as a public health problem through:
✔️ intensified vaccination against HPV
✔️ screening
✔️ treatment
bit.ly/35A3ajV
#CervicalHealthMonth
Datamonitor HC, Citeline Commercial retweeted
*Download a free copy* $GWPH Epidiolex and Epilepsy- big changes for medical marijuana. Explores DEA's likely reclassification and significance of the first FDA-approved plant-based medical marijuana for the epilepsy market & wider pharmaceutical market: pharmaintelligence.informa.c…
Datamonitor HC, Citeline Commercial retweeted
How a Rapid and Well-Messaged US FDA Offense Is Driving Spectators to Their Feet and Twitter Accounts
bit.ly/2N7IR4G #PinkSheet
Datamonitor HC, Citeline Commercial retweeted
Excellent piece on what makes @SGottliebFDA so unique- "The main special sauce ingredient to date is an urgent, well-planned, multi-flanked offensive. . .Communication is the second but most outwardly facing and obvious ingredient in the sauce. Gottlieb is a master."
How a Rapid and Well-Messaged US FDA Offense Is Driving Spectators to Their Feet and Twitter Accounts
bit.ly/2N7IR4G #PinkSheet
Datamonitor HC, Citeline Commercial retweeted
FDA unsurprisingly issues CRL for $AGN ulipristal acetate for abnormal uterine bleeding in women with uterine fibroids due to liver-related safety issues. This follows the EMA's PRAC assessment, recommending restricted use. allergan.com/News/News/Thoms…
Datamonitor HC, Citeline Commercial retweeted
Datamonitor HC, Citeline Commercial retweeted
A very insightful eBook on cell therapy here. #celltherapy #Immunotherapy
Read this new #eBook full of insight into cell therapy. Topics discussed include the commercial experience of cell and gene therapies – from manufacturing and patient experiences to payment models and reimbursements. bit.ly/2MsqcUk #cancers #Immunotherapy #celltherapy
ALT Read this new #eBook full of insight into cell therapy. Topics discussed include the commercial experience of cell and gene therapies – from manufacturing and patient experiences to payment models and reimbursements. http://bit.ly/2MsqcUk #cancers #Immunotherapy #celltherapy
Datamonitor HC, Citeline Commercial retweeted
The 2018 #XconomyAwards on Sept 5, part of @BiotechWkBoston, celebrate the people, companies & organizations that make the Boston life sciences ecosystem one of the most vibrant & innovative in the world. See the finalists & grab your tickets: xconomy.com/xconomy-awards-b… @Xconomy
Datamonitor HC, Citeline Commercial retweeted
CRAWLING CELL
Catching a single PtK1 cell crawling around is like seeing a white elk. Rare but majestic.
(PtK1- potoroo epithelial cell line)
#CellBiology
Datamonitor HC, Citeline Commercial retweeted
Biohaven Readies Glutamate Modulator BHV-0223 For Phase III In Anxiety
bit.ly/2we4dWP #PharmaScrip
Datamonitor HC, Citeline Commercial retweeted
Big FDA approval for @EisaiUS and $MRK's Lenvima in 1st line hepatocellular carcinoma. Nod verse active comparator will ramp up sales and send Lenvima on way to blockbuster status by 2020. @PharmaVitae @Datamonitor_HC #pharma eisai.mediaroom.com/2018-08-…
Datamonitor HC, Citeline Commercial retweeted
Wonderful news about Steve Rosenberg, Jim Allison & Carl June for 2018 @AlbanyMed Prize in Medicine & Biomedical Research. Their development of immunotherapy to treat cancer is being recognized for "altering the course of medical research." Congratulations to 3 Great Scientists!
Datamonitor HC, Citeline Commercial retweeted
Hopkins scientists explore the use of testosterone in the treatment of aggressive #ProstateCancer: #pcam bit.ly/2MhHmof
Datamonitor HC, Citeline Commercial retweeted
@RoseSheet goes beyond the headlines to provide in-depth analysis plus expert
coverage of the breaking news, to provide you the strategic insights you need to ensure
compliance, avoid litigation and capitalize on emerging opportunities. Learn More:
bit.ly/2w2R6aU
Datamonitor HC, Citeline Commercial retweeted
Out now for @INVIVOnow True Innovation In Women’s Health Hindered Because Conditions Are Not Fatal invivo.pharmaintelligence.in… #timesup #healthcare #WomensHealth
Datamonitor HC, Citeline Commercial retweeted
Watch how Art of Science winners @ansellbr3 and Balu Balan are using computational biology to stop the spread of #giardia. Exhibition info: wehi.edu.au/artofscience #ArtofScience
Datamonitor HC, Citeline Commercial retweeted
Here we go... $CVS $UNH
Ohio Medicaid firing PBMs due to "spread pricing" that cost taxpayers >$200 millions
gatehousenews.com/sideeffect…
Datamonitor HC, Citeline Commercial retweeted
Just sitting back and digesting the $PTLA call a bit more, could Bill Lis have been forced into retirement due to the abysmal Q2 numbers (specifically for Bevyxxa)?
I would imagine the preliminary numbers would have been ready internally rather quickly (AKA early June)
$PTLA reports 2.2M in Andexxa sales and 33K in Bevyxxa sales (down from 0.6M in Q1), far from encouraging numbers
Also announced appointment of chief HR officer, but no word on CEO replacement
Generation 2 manufacturing submission is expected by end of August
Datamonitor HC, Citeline Commercial retweeted
ARM/IQVIA report suggests additional value inputs, such as indirect costs, societal economic impact, be considered for regenerative medicine framework. This will require big shift in thinking by payers, many of whom focus just on medical cost offset bit.ly/2KG6D5Z
Datamonitor HC, Citeline Commercial retweeted
PhIII FREEDOM-EV results indicate that $UTHR Orenitram (a prostacyclin analog) delays PAH disease progression vs placebo, this data may help it better compete with prostacyclin receptor agonist $JNJ Uptravi ir.unither.com/news-releases…